| |
 |
|
Class Information
Number: 514/266.21
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,3-diazines (e.g., pyrimidines, etc.) > Polycyclo ring system having 1,3-diazine as one of the cyclos > Bicyclo ring system having the 1,3-diazine as one of the cyclos > Quinazoline (including hydrogenated)(i.e., the second cyclo in the bicyclo ring system is an ortho-fused six-membered carbocycle) > Additional hetero ring attached directly or indirectly to the quinazoline ring system by nonionic bonding > The additional hetero ring is six-membered consisting of one nitrogen and five carbons
Description: Subject matter wherein the additional hetero ring is six-membered consisting of five carbons and one nitrogen.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7390815 |
Pyrazole compounds useful as protein kinase inhibitors |
Jun. 24, 2008 |
| 7388014 |
Quinazoline derivatives and therapeutic use thereof |
Jun. 17, 2008 |
| 7381730 |
3-arylquinazoline derivatives as selective estrogen receptor beta modulators |
Jun. 3, 2008 |
| 7368445 |
Fused pyrazole derivatives as TGF-.beta. signal transduction inhibitors for the treatment of fibrosis and neoplasms |
May. 6, 2008 |
| 7348332 |
(3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines |
Mar. 25, 2008 |
| 7332493 |
Substituted bicyclic derivatives for the treatment of abnormal cell growth |
Feb. 19, 2008 |
| 7329664 |
Substituted (7-pyridyl-4-phenylamino-quinazolin-2-yl)-methanol analogues |
Feb. 12, 2008 |
| 7312209 |
Acridone inhibitors of IMPDH enzyme |
Dec. 25, 2007 |
| 7304059 |
Substituted quinazolin-4-ylamine analogues |
Dec. 4, 2007 |
| 7268142 |
Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline |
Sep. 11, 2007 |
| 7196094 |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
Mar. 27, 2007 |
| 7186720 |
Tetrahydropyridyl-alkyl-heterocycles, method for preparing the same and pharmaceutical compositions containing the same |
Mar. 6, 2007 |
| 7173040 |
Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derinazoline derivatives |
Feb. 6, 2007 |
| 7173038 |
Quinazoline derivatives as VEGF inhibitors |
Feb. 6, 2007 |
| 7091200 |
Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
Aug. 15, 2006 |
| 7074800 |
Quinazoline derivatives as angiogenesis inhibitors |
Jul. 11, 2006 |
| 7053095 |
Triazole compounds as transforming growth factor (TGF) inhibitors |
May. 30, 2006 |
| 6992084 |
Compounds and methods for modulating CXCR3 function |
Jan. 31, 2006 |
| 6992092 |
Anti-diabetic agents |
Jan. 31, 2006 |
| 6982260 |
Quinazolines and their use for inhibiting cyclin-dependent kinase enzymes |
Jan. 3, 2006 |
| 6962922 |
Alkynylated quinazoline compounds |
Nov. 8, 2005 |
| 6953793 |
Substituted pyrazoles |
Oct. 11, 2005 |
| 6949541 |
Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
Sep. 27, 2005 |
| 6936619 |
Quinazolinone compounds useful in therapy |
Aug. 30, 2005 |
| 6911446 |
Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds |
Jun. 28, 2005 |
| 6903096 |
Quinazoline derivatives as medicaments |
Jun. 7, 2005 |
| 6900220 |
Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
May. 31, 2005 |
| 6897214 |
Quinazoline derivatives |
May. 24, 2005 |
| 6890924 |
Substituted bicyclic derivatives for the treatment of abnormal cell growth |
May. 10, 2005 |
| 6867217 |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
Mar. 15, 2005 |
| 6867208 |
Vitronectin receptor antagonists, their preparation and their use |
Mar. 15, 2005 |
| 6844349 |
Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-a cetamide and method of production |
Jan. 18, 2005 |
| 6794389 |
Quinazoline derivatives and drugs |
Sep. 21, 2004 |
| 6774129 |
Benzothieno[3,2-c]pyridines as .alpha.2 antagonists |
Aug. 10, 2004 |
| 6770641 |
Fused heteroaryl derivatives |
Aug. 3, 2004 |
| 6759410 |
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors |
Jul. 6, 2004 |
| 6699861 |
Anti-quinazoline compounds |
Mar. 2, 2004 |
| 6683085 |
Salt form and polymorphs |
Jan. 27, 2004 |
| 6610678 |
CRF antagonistic quino-and quinazolines |
Aug. 26, 2003 |
| 6586430 |
CCR5 modulators |
Jul. 1, 2003 |
| 6579885 |
Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof |
Jun. 17, 2003 |
| 6559153 |
Quinazoline derivatives as alpha-1 adrenergic antagonists |
May. 6, 2003 |
| 6528512 |
Pyrimidine compounds useful in treating cytokine mediated diseases |
Mar. 4, 2003 |
| 6525067 |
Substituted heterocyclic derivatives |
Feb. 25, 2003 |
| 6525076 |
Selective factor Xa inhibitors |
Feb. 25, 2003 |
| 6521629 |
Quinoline and quinazoline compounds useful in therapy |
Feb. 18, 2003 |
| 6514988 |
Condensed-ring thiophene derivatives, their production and use |
Feb. 4, 2003 |
| 6495555 |
Tricyclic .DELTA.-3-piperidines as .alpha.2-antagonists |
Dec. 17, 2002 |
| 6479505 |
6-arylphenanthridines with PDE-IV inhibiting activity |
Nov. 12, 2002 |
| 6476031 |
Quinazoline derivatives as medicaments |
Nov. 5, 2002 |
|
|
|
